Cambrex Corp.
(NYSE:
CBM)
Biotechnology - Healthcare
|
| Last Price |
Today's Change |
Day's Range |
Volume |
| $6.81 |
-0.05
(-0.73 %)
|
$6.67 - $6.96 |
82.62K
|
|
| |
| Previous Close |
$6.86 |
|
|
Average Volume |
144.99K
|
| Open |
$6.84 |
|
|
EPS |
0.46 |
| Market Cap |
0.20B
|
|
|
PE |
14.89 |
| Shares Outstanding |
29.62M
|
|
|
Relative Strength Index (14) |
50.07 |
| Float Shares |
29.06M
|
|
|
Moving Average (20) |
0.07 % |
| Institutional Ownership |
94.66 % |
|
|
Moving Average (50) |
0.44 % |
| Insider Ownership |
0.21 % |
|
|
Moving Average (200) |
5.73 % |
| Beta |
1.22 |
|
|
Analyst Recommendation |
Hold |
| Dividend Yield |
0.0 % |
|
|
Earnings Date |
May 3, 2012 |
|
| |
Performance Metrics |
| Week |
Month |
Quarter |
Half Year |
Year |
|
-0.44
%
|
12.48
%
|
-9.03
%
|
7.54
%
|
37.27
%
|
|
| |
| |
Company Information |
Cambrex Corporation, a life sciences company, provides products and services for the development and commercialization of new and generic therapeutics. Its products include active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, and other custom chemicals derived from organic chemistry. The company sells its products through sales agents and independent agents to pharmaceutical and generic drug companies worldwide. Cambrex Corporation was founded in 1981 and is based in East Rutherford, New Jersey.
|
|
| Last Price |
Today's Change |
Day's Range |
Volume |
| $6.81 |
-0.05
(-0.73 %)
|
$6.67 - $6.96 |
82.62K
|
|
| |
| |
|
|
|
| Last Price |
Today's Change |
Day's Range |
Volume |
| $6.81 |
-0.05
(-0.73 %)
|
$6.67 - $6.96 |
82.62K
|
|
| |
| |
|
|
